40 related articles for article (PubMed ID: 21437587)
1. Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).
Kang HJ; Lee SS; Kim KM; Choi TH; Cheon GJ; Kim WS; Suh C; Yang SH; Lim SM
Asia Pac J Clin Oncol; 2011 Jun; 7(2):136-45. PubMed ID: 21585693
[TBL] [Abstract][Full Text] [Related]
2. Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
Du Y; Honeychurch J; Glennie M; Johnson P; Illidge T
Cancer Res; 2007 Feb; 67(3):1335-43. PubMed ID: 17283171
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
Postema EJ; Boerman OC; Oyen WJ; Raemaekers JM; Corstens FH
Eur J Nucl Med; 2001 Nov; 28(11):1725-35. PubMed ID: 11702116
[TBL] [Abstract][Full Text] [Related]
4. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.
Lamborn KR; DeNardo GL; DeNardo SJ; Goldstein DS; Shen S; Larkin EC; Kroger LA
Clin Cancer Res; 1997 Aug; 3(8):1253-60. PubMed ID: 9815807
[TBL] [Abstract][Full Text] [Related]
6. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
Bonnekoh B; Schulz M; Franke I; Gollnick H
J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
[TBL] [Abstract][Full Text] [Related]
7. Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
Behr TM; Wörmann B; Gramatzki M; Riggert J; Gratz S; Béhé M; Griesinger F; Sharkey RM; Kolb HJ; Hiddemann W; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3304s-3314s. PubMed ID: 10541379
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of primary non-Hodgkin's lymphoma of the vulva with radiation therapy.
Tokatli F; F Oz-Puyan F; Alas R; Usta U; Yilmaz H; Uzal C
J BUON; 2009; 14(1):119-22. PubMed ID: 19365881
[TBL] [Abstract][Full Text] [Related]
9. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
[No Abstract] [Full Text] [Related]
10. Antibody localization to B-cell lymphoma xenografts in immunodeficient mice: importance of using residualizing radiolabels.
Michel RB; Ochakovskaya R; Mattes MJ
Clin Cancer Res; 2002 Aug; 8(8):2632-9. PubMed ID: 12171895
[TBL] [Abstract][Full Text] [Related]
11. When is a predose a dose too much?
Illidge T; Du Y
Blood; 2009 Jun; 113(23):6034-5. PubMed ID: 19498030
[No Abstract] [Full Text] [Related]
12. Bulky aggressive B-cell lymphoma: to radiate or not to radiate--that is the question.
Kahl BS
J Clin Oncol; 2014 Apr; 32(11):1097-8. PubMed ID: 24550422
[No Abstract] [Full Text] [Related]
13. Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma.
Reitter S; Rohn A; Schmidt HH; Linkesch W
Ann Hematol; 2012 Jan; 91(1):129-30. PubMed ID: 21437587
[No Abstract] [Full Text] [Related]
14. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Nowakowski GS; Witzig TE
Clin Adv Hematol Oncol; 2006 Mar; 4(3):225-31. PubMed ID: 16728934
[TBL] [Abstract][Full Text] [Related]
15. [Radio-immunotherapy for B-cell non-Hodgkin lymphoma].
Visser OJ; Zijlstra JM; van Dongen GA; Huijgens PC
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2324-8. PubMed ID: 16261710
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
Dillman RO
Curr Hematol Rep; 2003 Jan; 2(1):30-7. PubMed ID: 12901152
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
